Literature DB >> 23276732

Dopamine D1 receptors mediate dopamine-induced duodenal epithelial ion transport in rats.

Xiao-Yan Feng1, Yun Li, Li-Sheng Li, Xiao-Feng Li, Li-Fei Zheng, Xiao-Li Zhang, Rui-Fang Fan, Jin Song, Feng Hong, Yue Zhang, Jin-Xia Zhu.   

Abstract

Dopamine (DA) is synthesized in gastrointestinal epithelial cells and performs important regulatory effects on the duodenal mucosa. However, the underlying mechanism remains largely unknown. The present study investigated the effect of DA on the duodenal epithelial ion transport in rats by means of short-circuit current (ISC), real-time pH titration, enzyme-linked immunosorbent assay, and immunohistochemistry. The results indicate that basolateral, but not apical, application of DA induced a concentration-dependent ISC downward deflection with an apparent IC50 of 5.34 μmol/L. Basolateral application of dopaminergic receptor D1 (D1) antagonist, SCH-23390, inhibited DA-induced change in ISC (△ISC) in a dose-dependent manner. D1 agonist, SKF38393, mimicked the effect of DA on the ISC. The clear immunoreactivity of D1 subtype D5 (D1b) was at the both apical and basolatoral sides of Brunner's glands and intestinal crypts. Basolateral pretreatment with adenylate cyclase inhibitor, MDL12330A, significantly inhibited DA- and forskolin-induced △ISC. DA and SKF38393 increased the level of intracellular cyclic adenosine monophosphate (cAMP) from 1.55 ± 0.11 to 2.07 ± 0.11 and 5.91 ± 0.25 pmol/L·mg(-1), respectively. Furthermore, the serosal DA-induced △ISC was remarkably inhibited by apical administration of K(+) channel blockers, Ba(2+) and tetraethylammonium, but not by Cl(-) channel blockers. Serosal DA and D1 agonist did not affect duodenal HCO3(-) secretion. In conclusion, the present results demonstrate that serosal DA is able to promote rat duodenal epithelial K(+) secretion, not HCO3(-) secretion through D1-mediated and cAMP-dependent pathway. The study provides a new insight in the modulation of DA on the ion transport of duodenal epithelia in rats.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23276732     DOI: 10.1016/j.trsl.2012.12.002

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  8 in total

1.  Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease.

Authors:  Li-Sheng Li; Chen-Zhe Liu; Jing-Dong Xu; Li-Fei Zheng; Xiao-Yan Feng; Yue Zhang; Jin-Xia Zhu
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Gut microbiota in hypertension.

Authors:  Pedro A Jose; Dominic Raj
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

3.  Source of dopamine in gastric juice and luminal dopamine-induced duodenal bicarbonate secretion via apical dopamine D2 receptors.

Authors:  Xiao-Yan Feng; Jing-Ting Yan; Guang-Wen Li; Jing-Hua Liu; Rui-Fang Fan; Shi-Chao Li; Li-Fei Zheng; Yue Zhang; Jin-Xia Zhu
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

Review 4.  The dopaminergic system in autoimmune diseases.

Authors:  Rodrigo Pacheco; Francisco Contreras; Moncef Zouali
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

5.  Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl- and HCO3- channel.

Authors:  Cheng Yang; Ying Xiong; Sheng-Sheng Zhang; Fang-Mei An; Jing Sun; Qing-Lin Zhang; Qiang Zhan
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

Review 6.  The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension.

Authors:  Waleed N Qaddumi; Pedro A Jose
Journal:  Biomedicines       Date:  2021-02-01

Review 7.  The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure?

Authors:  Souhaila Al Khodor; Bernd Reichert; Ibrahim F Shatat
Journal:  Front Pediatr       Date:  2017-06-19       Impact factor: 3.418

8.  Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action of Huo-Xiang-Zheng-Qi Formula for the Treatment of Gastrointestinal Diseases.

Authors:  Miaoqing Zhao; Yangyang Chen; Chao Wang; Wei Xiao; Shusheng Chen; Shuwei Zhang; Ling Yang; Yan Li
Journal:  Front Pharmacol       Date:  2019-01-11       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.